Pharmacogenetic Panel to Prevent Adverse Drug Reactions in Daily Primary Care Practice:

Clinical trial NCT06322238 · RECRUITING

Trial details

NCT number: NCT06322238
Sponsor: Mayo Clinic
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pharmacogenomic Drug Interaction Side Effect of Drug Ineffective Drug Action Drug Metabolism, Poor, CYP2D6-Related Drug Metabolism, Poor, CYP2C19-Related

Start date: 2024-12-01
Primary completion: 2026-12-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.